9 Analysts Assess MetLife: What You Need To Know
Portfolio Pulse from Benzinga Insights
Analysts have provided mixed ratings for MetLife (NYSE:MET) over the past three months, with a majority being somewhat bullish. The average 12-month price target has increased to $84.0. MetLife's financials show revenue growth but lag behind industry peers in net margin, ROE, and ROA. The company's debt-to-equity ratio is higher than the industry average, indicating higher financial risk.
June 28, 2024 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Analysts have mixed ratings for MetLife, with a majority being somewhat bullish. The average 12-month price target has increased to $84.0. MetLife's financials show revenue growth but lag behind industry peers in net margin, ROE, and ROA. The company's debt-to-equity ratio is higher than the industry average, indicating higher financial risk.
The mixed analyst ratings and the increase in the average 12-month price target suggest a neutral short-term impact on MetLife's stock price. While the financials show revenue growth, the lag in net margin, ROE, and ROA, along with a high debt-to-equity ratio, indicate potential financial challenges. These factors balance each other out, leading to a neutral short-term impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100